AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.